Pain Casts A Shadow
On Everyday Life
for Hundreds of Millions of People Worldwide
Learn More >>
Medasense’s
Breakthrough
AI Technology
Quantifies Pain to Personalize Treatment
Learn More >>
Visualizing Pain
for Confident Pain Management
Learn More >>
Previous slide
Next slide

Treating Pain is at the Heart of Medicine

Pain is a major clinical, social and economic problem, affecting quality of life for hundreds of millions of people globally and with annual costs exceeding $1T.1,2 Medasense is transforming the way pain is being assessed and treated worldwide.

Through our breakthrough NOL® AI technology and sensor platform, we quantify pain response to optimize care and avoid overmedication. Medasense’s flagship product, PMD-200™, is used in critical care settings, to visualize pain response and personalize treatment. Our pipeline products apply Medasense’s AI capabilities to lead pain prediction, stratification and prevention strategies.

Industry Collaborations and Commercial Partners

Eliminate guesswork and meet clinical challenges in assessing pain and improving analgesia.

Clinical Evidence

Clinical studies have demonstrated the impact that NOL monitoring has on patient safety,3 outcomes and savings,4 including 33% reduction in reported postoperative pain.5

Medasense Academy

Welcome to our online and customized education and training program for clinicians and commercial partners.

Latest News

Study has found that monitoring pain levels during surgery with NOL can help reduce intraoperative opioid usage and postop pain up to 3 days after surgery.

>

Medasense, a global leader in pain monitoring solutions, is proud to announce a strategic partnership with Nihon Kohden for the exclusive distribution of its revolutionary pain monitoring device in Japan.

>

Medasense, a pioneer in pain monitoring technology, has announced a strategic agreement with Panakeia, LLC, a Service-Disabled Veteran-Owned Small Business and a leading healthcare solutions provider, to distribute Medasense’s PMD-200 device to United States government institutions.

>

Global Distribution Network

Click on the map to view in full size

Highlights

Medasense - Our Vision: Transforming the way pain is being assessed and treated worldwide

Play Video

Meeting the challenge of intraoperative pain monitoring

Play Video

Leading clinicians on the importance of monitoring the patient’s pain response level

Play Video

Experience NOL monitoring with the NOL Simulation Hub

REFERENCES:
1. Darrell J. Gaskin, Patrick Richard. The Economic Costs of Pain in the United States. The Journal of Pain, 2012; 13 (8): 715 DOI: 10.1016/j.jpain.2012.03.009
2. EuroStat. Eurostat News release. Eurostat. [Online] 3 30, 2017. https://ec.europa.eu/eurostat/documents/2995521/7962764/1-30032017-AP-EN.pdf/. 52/2017.
3. Meijer, F., Martini, C., Broens, S., Boon, M., Niesters, M., Aarts, L., Olofsen, E., van Velzen, M., Dahan, A. (2019). Nociception-guided versus Standard Care during Remifentanil–Propofol Anesthesia: A Randomized Controlled Trial. Anesthesiology, 130(5), 745-755. doi:10.1097/ALN.0000000000002634
4. Saunders R., Weissbrod R. (2020). Cost benefit of personalizing intraoperative pain management. Presented at ISPOR Virtual Conference, May 2020
5. Meijer, F., Honing, M., Roor, T., Toet, S., Calis, P., Olofsen, E., Martini, C., van Velzen, M., Aarts, L., Niesters, M., Boon, M., Dahan, A. (2020). Reduced postoperative pain using Nociception Level-guided fentanyl dosing during sevoflurane anaesthesia: a randomised controlled trial. British Journal of Anaesthesia, 125(6), 1070-1078.